Xoma Depositary Shares Rep Series B 8.375% Cumulative Preferred StockXOMAO
XOMAO
$25.38
0.4%
About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.
Employees: 13
–
Funds holding %
of 6,710 funds
–
Analysts bullish %
Fund manager confidence
Research analyst outlook
We haven’t received any recent analyst ratings for XOMAO.
Financial journalist opinion
We haven’t received any recent news articles for XOMAO.